series-c-plus
Stage
2
Investors
About
Ultragenyx is a biopharmaceutical company that discovers, develops, and commercializes therapies for rare and ultra-rare genetic diseases. Its programs include biologics and gene therapy approaches to address enzyme deficiencies and other inherited disorders.
Explore Ultragenyx's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.